|
HS Code |
818561 |
As an accredited 1,3-Bis(Bromomethyl)Benzene factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 1,3-Bis(Bromomethyl)Benzene prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Chemistry students and experienced scientists alike have crossed paths with 1,3-Bis(Bromomethyl)Benzene, often called m-Xylylene dibromide. This compound rarely grabs headlines, but it plays a quiet, vital role in laboratories and manufacturing plants around the world. With the molecular formula C8H8Br2, it brings two reactive bromomethyl groups attached to a benzene ring in positions 1 and 3. This arrangement unlocks pathways that many other benzene derivatives can’t reach, especially when searching for ways to introduce functional groups into linear or cyclic organic structures.
Having handled this compound in a university research setting, I’ve come to respect the practical value of its chemical flexibility. For chemists who aim to build larger, more complex molecules, such as pharmaceuticals or specialty polymers, 1,3-Bis(Bromomethyl)Benzene often performs key steps that other reagents can’t match as directly. The placement of the bromomethyl groups prevents unwanted reactions between neighboring substituents that might occur in the more familiar 1,2- or 1,4-analogs, giving more predictable selectivity and yield.
1,3-Bis(Bromomethyl)Benzene usually comes as a white to off-white crystalline solid with a melting point that hovers between 90°C and 94°C. This physical consistency means it’s straightforward to weigh and handle without special precautions against volatility. Standard packaging most often contains 98% or greater purity, since many end users—especially in pharmaceutical research—care about minimizing side reactions from impurities. Even in large-scale manufacturing, paying for higher purity saves companies on downstream purification expenses and avoids surprises during critical experiments.
It isn’t just about purity, though. Particle size distribution and moisture content have a real effect on how 1,3-Bis(Bromomethyl)Benzene behaves in different synthetic methods. Larger, dry, free-flowing crystals dissolve well in most common organic solvents, like dichloromethane or toluene, making scale-up less painful. Technicians and operators notice the time saved in weighing and mixing when they don’t have to deal with caking or fine dust formation.
What stands out about 1,3-Bis(Bromomethyl)Benzene is its double functionality. Each bromomethyl group acts as a leaving group—a site primed for nucleophilic substitution. Lab colleagues often employ it as a versatile linker: attach two separate molecules to the benzene core, and suddenly you’ve built a new dimer or a polymer precursor. That’s the secret behind its popularity in the synthesis of macrocyclic crown ethers, which can serve as ligands for metal ions or as building blocks in supramolecular chemistry.
In my own work, I’ve watched as this compound bridges small amines, transforming two simple building blocks into a rigid, predictable scaffold in a matter of hours. Contrast this with processes based on chloro-substituted analogs. Bromides react faster and more cleanly, so less time and energy go into keeping batch reactors at high temperatures or purifying out endless byproducts. For medicinal chemists, this can shave weeks off a development timeline, reducing costs and resource usage.
Beyond drug discovery, industrial chemists turn to 1,3-Bis(Bromomethyl)Benzene when they need spacer molecules in the design of specialty polyimides and epoxy resins. These materials, prized for their electrical insulation and mechanical performance, owe a slice of their reliability to the even spacing and robust bonds provided by the meta-configured bromomethyl groups. The electronics industry, for instance, relies on these qualities for semiconductors and advanced circuit boards, where even minor improvements in polymer uniformity translate to big advances in product reliability and heat resistance.
People often ask what sets 1,3-Bis(Bromomethyl)Benzene apart from its relatives—particularly the 1,2- and 1,4- bis(bromomethyl)benzene isomers. It’s easy to assume these compounds do the same jobs, but that’s rarely the case. Many reactions call for a meta-substituted structure where ortho- or para- versions would simply fold back on themselves or lead to crosslinked byproducts too early in the synthesis. With 1,3-Bis(Bromomethyl)Benzene, chemists can design longer-chain polymers, cyclic structures, or multidentate ligands with more control over the final architecture. The difference in reactivity and molecular distance between functional groups can dictate the mechanical or electronic properties of the finished product.
As someone who has worked with both 1,2- and 1,3- bis(bromomethyl)benzene analogs, the experience with 1,3- is often preferable, especially for researchers troubleshooting unwanted side reactions. The ortho isomer tends to cyclize too quickly, while the para isomer sometimes doesn’t offer enough structural diversity for certain advanced materials, especially when symmetry in the final product leads to solubility or crystallization challenges.
Regulatory standards also help define practical differences. 1,3-Bis(Bromomethyl)Benzene often falls into lower risk categories in certain jurisdictions due to its less aggressive reactivity in environmental or workplace exposures compared to chlorinated analogs. That said, as with all reactive organic compounds, safe handling procedures and proper PPE remain essential in any laboratory or production environment.
Suppose a team of chemical engineers is scaling up a reaction for pilot plant testing. Any hint of contamination in the 1,3-Bis(Bromomethyl)Benzene raw material—whether residual solvents, unreacted toluene starting material, or hydrolysis byproducts—can throttle both reaction rate and final yield. I’ve seen a kilo-scale polymerization stall completely because a cheaper source of this compound came laced with just enough moisture to hydrolyze one of the bromomethyl groups. That sort of error leads to wasted time, money, and a spike in frustration.
This is why reputable suppliers go beyond minimum standards. They analyze each batch using gas chromatography and nuclear magnetic resonance (NMR) to identify possible impurities before shipping. Some labs order additional analytical certificates or run their own quality checks on-site. The cost of a ruined experiment or batch outweighs the savings of a cut-rate source.
Trends point toward greener, more sustainable synthesis of aromatic chemicals. Traditional routes to 1,3-Bis(Bromomethyl)Benzene often use hazardous reagents like hydrobromic acid and formaldehyde with high solvent loads. These processes generate significant waste, raise worker safety flags, and attract scrutiny from environmental agencies.
Room exists for process innovation. One avenue involves milder, catalytic bromination methods, which could lower the need for excess reagents and reduce unwanted byproducts. Switching to continuous flow synthesis can help too; these setups increase yield, cut energy costs, and make automation easier for growing companies. Research labs experimenting with phase-transfer catalysts have posted some success in improving selectivity while using less hazardous reagents. Another area ripe for exploration: recycling or reusing spent solvents and brominating agents.
Demand for cleaner, safer compounds in electronics and biotech will keep up the pressure for greener processing. Even academic labs can do their part by adopting microscale procedures or by substituting hazardous solvents for friendlier alternatives.
Stories from the laboratory bench remind us that even well-characterized materials like 1,3-Bis(Bromomethyl)Benzene aren’t immune to practical challenges. Some colleagues find the compound irritating to the skin or eyes during weighing and transfer operations. Ventilated enclosures, gloves, and goggles should be routine in any space where it’s handled. Small spills can be addressed quickly with an appropriate absorbent, but workplace hygiene drills pay off in minimizing exposure and maintaining morale.
Mistakes in storage and transport can also sap value from even the highest purity batch. Traveling too long at elevated temperature can darken the crystals, signaling possible decomposition. I remember one shipment arriving sticky and clumped after a summer freight delay; our lab had to run time-consuming purification steps before salvaging any usable material. Cool, dry storage, in sealed containers, remains one of the cheapest investments in quality assurance.
To put it plainly, choice of raw material ripples through every layer of research and production. A project as routine as designing a new type of epoxy resin hinges on the minute differences between isomers or on the reliability of supply. 1,3-Bis(Bromomethyl)Benzene enables access to specific properties and structures that might open doors in entirely new markets — such as advanced membrane materials, smart drug delivery platforms, or specialty adhesives capable of withstanding oddball environments.
Product designers and materials scientists working on the next generation of components for aerospace or medical implants might spend weeks dialing in a polymer chain architecture, only to find out that their vendor switched to a lower-grade aromatic bromide, triggering a subtle shift in performance. Such setbacks highlight why maintaining open dialogue with suppliers, reviewing fit-for-purpose quality metrics, and batch-tracing source materials can head off costly surprises.
Most research institutions and manufacturing companies must follow local, national, and even international chemical safety standards that frame how 1,3-Bis(Bromomethyl)Benzene can be moved, stored, and used. Its potential as a reactive alkylating agent puts it on the radar for health and safety reviews—particularly in the European Union and North America, where chemical registration and risk assessments define who gets to buy, sell, or transport each batch. These policies keep workplace risks under control while fostering innovation.
Regular audits, chemical inventory tracking, and dedicated waste disposal containers reduce exposure and environmental impact. It makes sense for managers and lab supervisors to instill a culture where the rules don’t look like suggestions. Reflecting on past incidents, continuous attention to training and communication goes a long way in keeping facilities out of trouble.
Behind every kilogram of 1,3-Bis(Bromomethyl)Benzene lies a network of growers, shippers, suppliers, and end-users — connected by shared responsibility. Researchers swapping notes online often warn others about unreliable vendors or poorly labeled shipments, keeping standards high across borders. Open discussion drives incremental improvements, whether it’s a better purification method, a solvent swap that cuts costs, or the discovery of a new application in energy storage or advanced coatings.
A spirit of communication builds trust across the chemical industry and academic communities. Graduate students just starting out benefit when postdocs and mentors pass down hard-won lessons about the quirks of specialty chemicals. Explicit conversations about quality, safety, and regulatory compliance save time, money, and effort that can be funneled into groundbreaking projects rather than fire-fighting mishaps.
As technology advances, demand for specialty aromatic linkers like 1,3-Bis(Bromomethyl)Benzene will only grow. The semiconductors, advanced plastics, and targeted drug treatments of tomorrow will lean on reliable, high-purity sources to hit ever-tighter tolerances. This brings both opportunity and responsibility for companies across the supply chain. Lessons from current users suggest that staying ahead of regulatory changes, pursuing greener synthesis routes, and investing in quality assurance can secure long-term success.
In my view, researchers who keep exploring new uses and alternative processing routes will help redefine what’s possible with meta-substituted benzene compounds. As the research landscape broadens—spanning energy, electronics, medicine, and sustainability—the practical experiences of today’s chemists will chart a smarter, safer path forward for everyone who works with or benefits from these potent chemical building blocks.